Skip to main content
Signal8

Cordova Ashley

SEC insider (Form 3/4/5 filer). CIK 0001822014. Former Chief Executive Officer at NovoCure Ltd (NVCR). 13 reported Form 4/5 transactions since Sep 2024; latest on Mar 4, 2026. Located in WAYNE, PA.

Companies Cordova Ashley has filed insider reports for

  • NovoCure Ltd (NVCR): Officer, Former Chief Executive Officer
Cordova Ashley profile photo

Cordova Ashley

CIK: 0001822014

Transaction Breakdown

Open Market Buys (P)1 (7.7%)

High conviction signal

Open Market Sales (S)4 (30.8%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (30.8%)

Compensation grants

Other (G, F, J, C, D, …)4 (30.8%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NovoCure Ltd logo
NVCR

NovoCure Ltd

Officer

Discretionary Trading P&L

Holdings

Transaction History (13 total)

  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Mar 4, 2026
    Tax Payment
    Direct
    17.6K shares at avg. $13.30$235K
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Mar 2, 2026
    Tax Payment
    Direct
    2.4K shares at avg. $13.67$33K
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Mar 2, 2026
    Tax Payment
    Direct
    7.2K shares at avg. $13.67$99K
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Feb 28, 2026
    Award
    Direct
    23.8K shares-
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Feb 27, 2026
    Tax Payment
    Direct
    11.5K shares at avg. $13.75$159K
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Sep 5, 2025
    Purchase
    Direct
    81.6K shares at avg. $12.22$997K
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Jun 30, 2025
    Award
    Direct
    833 shares at avg. $15.13$13K
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Mar 4, 2025
    Award
    Direct
    151.2K shares at avg. $18.19$2.7M
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Mar 3, 2025
    Sale
    Direct
    2.1K shares at avg. $18.54$38K
  • NovoCure Ltd logo
    NVCR

    NovoCure Ltd

    Feb 28, 2025
    Sale
    Direct
    2.3K shares at avg. $18.28$43K

1-10 of 13